Zosano Pharma Corp 4 SEC Filings

Filed On	Filing
07 Jun 2022	Form 4: Matthews Christine, Chief Financial Officer Sold 82 shares ($58.2)
07 Jun 2022	Form 4: Lo Steven, Director Sold 442 shares ($314)
01 Apr 2022	Form 4: Matthews Christine, Chief Financial Officer Sold 8,116 shares ($1.71K)
01 Apr 2022	Form 4: Kellerman Donald J, VP, Clinical Dev & Med Affairs Sold 4,006 shares ($842)
01 Apr 2022	Form 4: Lo Steven, Director Sold 23,633 shares ($4.97K)
09 Dec 2021	Form 4: Yang Elaine, Director Granted 90,000 Stock Option (Right to Buy)
24 Nov 2021	Form 4: Greathouse Kenneth, Director Sold 10,000 shares ($6.02K)
19 Oct 2021	Form 4: Kellerman Donald J, VP, Clinical Dev & Med Affairs Received 10,000 shares as a grant or award · Granted 20,000 Stock Option (Right to Buy)
19 Oct 2021	Form 4: Matthews Christine, Chief Financial Officer Received 56,250 shares as a grant or award · Granted 112,500 Stock Option (Right to Buy)
19 Oct 2021	Form 4: Lo Steven, Director Received 118,750 shares as a grant or award · Granted 237,500 Stock Option (Right to Buy)
14 Jun 2021	Form 4: Grais Linda, Director Received 15,000 shares as a grant or award · Granted 30,000 Stock Option (Right to Buy)
14 Jun 2021	Form 4: Elms Steve, Director Received 15,000 shares as a grant or award · Granted 30,000 Stock Option (Right to Buy)
14 Jun 2021	Form 4: Greathouse Kenneth, Director Received 15,000 shares as a grant or award · Granted 30,000 Stock Option (Right to Buy)
14 Jun 2021	Form 4: Xanthopoulos Kleanthis G, Director Received 15,000 shares as a grant or award · Granted 30,000 Stock Option (Right to Buy)
14 Jun 2021	Form 4: Hagan Joseph P, Director Received 15,000 shares as a grant or award · Granted 30,000 Stock Option (Right to Buy)
07 Jun 2021	Form 4: Lo Steven, Director Sold 13,158 shares ($10.6K)
07 Jun 2021	Form 4: Lewis Hayley, See Remarks Sold 1,709 shares ($1.38K)
07 Jun 2021	Form 4: Kellerman Donald J, VP, Clinical Dev & Med Affairs Sold 1,709 shares ($1.38K)
07 Jun 2021	Form 4: Matthews Christine, Chief Financial Officer Sold 1,709 shares ($1.38K)
25 May 2021	Form 4: McGee Kathy M., Director Granted 90,000 Stock Option (Right to Buy)

Comments